ScholarIQanswers from OpenAlex
Five Prime Therapeutics
FunderResearch funding and supported work
Five Prime Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
What is known about Five Prime Therapeutics?
ScholarIQrecord summary
company in South San Francisco, United States
How many works does Five Prime Therapeutics have?
ScholarIQindexed works
Five Prime Therapeutics has 232 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Five Prime Therapeutics?
ScholarIQopenalex
The OpenAlex for Five Prime Therapeutics is on the source record.
What is the ROR of Five Prime Therapeutics?
ScholarIQror
The ROR for Five Prime Therapeutics is on the source record.
What are the most-cited papers on Five Prime Therapeutics?
ScholarIQmost cited works
<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane, Kathryn C. Arbour, Joel W. Neal, Hatim Husain, Tracey L. Evans, Julie R. Brahmer, Alona Muzikansky, Philip Bonomi, Salvatore Del Prete, Anna Wurtz, Anna F. Farago, Dora Dias‐Santagata, Mari Mino–Kenudson, Karen L. Reckamp, Helena A. Yu, Heather A. Wakelee, Frances A. Shepherd, Zofia Piotrowska, Lecia V. Sequist